Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	118.21	166.73	51.7	81.31	28.45
Short-Term Investments	69.36	126.15	63.19	84.48	18.32
Cash & Short-Term Investments	187.58	292.87	114.9	165.78	46.77
Cash Growth	-35.95%	154.91%	-30.70%	254.46%	-31.74%
Accounts Receivable	13.43	14.74	19.66	17.28	20.83
Inventory	19.98	20.74	20.53	21.47	20.83
Other Current Assets	233.28	47.52	3.13	4.28	4.47
Total Current Assets	454.26	375.88	158.22	208.82	72.07
Net Property, Plant & Equipment	46.01	49.34	54.85	59.54	65.15
Other Intangible Assets	-	-	1.4	12.6	27.93
Goodwill	-	-	106.32	106.25	106.38
Long-Term Investments	25.7	-	-	-	-
Other Long-Term Assets	41.78	187.12	2.29	3.11	3.69
Total Assets	567.75	612.35	323.07	390.31	275.21
Accounts Payable	5.41	5.05	9.24	7.91	10.6
Accrued Expenses	29.78	21.44	21.02	15.33	13.59
Short-Term Debt	-	-	-	-	6.84
Current Portion of Long-Term Debt	-	-	59.53	2.08	-
Current Portion of Leases	5.49	4.81	4.32	3.68	3.05
Unearned Revenue	42	13.8	15.22	14.44	15.48
Other Current Liabilities	25.63	20.8	-	-	-
Total Current Liabilities	108.31	65.9	109.33	43.44	49.57
Long-Term Debt	0.3	0.3	3.98	62.81	64.21
Long-Term Leases	25.04	25.59	30.37	34.08	37.55
Other Long-Term Liabilities	9.82	48.84	16.18	20.19	29.29
Total Long-Term Liabilities	35.16	74.73	50.54	117.08	131.05
Total Liabilities	143.46	140.62	159.87	160.52	180.62
Common Stock	-	0.4	0.08	0.08	0.08
Treasury Stock	-	-46.47	-5.98	-0.56	-
Additional Paid-in Capital	-	1,702	860.82	847.01	831.42
Accumulated Other Comprehensive Income	-	1.23	-2.22	-1.9	-0.91
Retained Earnings	-	-1,186	-1,001	-926.1	-736
Total Common Shareholders' Equity	-	471.72	-148.05	-81.47	94.6
Minority Interest	-	-	311.25	311.25	-
Shareholders' Equity	-	471.72	163.2	229.79	94.6
Total Liabilities & Equity	567.75	612.35	323.07	390.31	275.21
Total Debt	30.83	30.7	98.21	102.66	111.65
Net Cash (Debt)	156.75	262.18	16.69	63.13	-64.88
Net Cash Growth	-40.21%	1471.35%	-73.57%	-	-
Net Cash Per Share	0.41	0.74	0.21	0.81	-0.47
Book Value	0	471.72	-148.05	-81.47	94.6
Book Value Per Share	-	1.34	-1.87	-1.04	0.69
Tangible Book Value	0	471.72	-255.77	-200.32	-39.71
Tangible Book Value Per Share	-	1.34	-3.23	-2.56	-0.29

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q